Mantle cell lymphoma: a Turkish Multi-Center Study.
J BUON
; 24(5): 2084-2089, 2019.
Article
em En
| MEDLINE
| ID: mdl-31786879
ABSTRACT
PURPOSE:
Mantle Cell Lymphoma (MCL) is a B-cell neoplasm with CCND1 [t(11;14)(q13;q32), cyclin D1] translocation. The guidelines recommend various treatment options based on age, performance status and comorbidities. Our purpose was to analyze the clinical features and evaluate prognostic factors for survival of 78 MCL patients.METHODS:
We retrospectively analyzed all MCL patients in two reference Hematology Departments between January 2001 and September 2018.RESULTS:
The patient median age was 62 years (34-86) and 78.2% of them were male. The treatment regimens were RïCHOP in 42.3%, RïBendamustine in 26.9%, HyperCVAD in 9% and RïCHOP/RïDHAP alternating in 7.7%. Only 13 patients underwent autologous stem cell transplantation. Median overall survival (OS) was 77.8 months (53.8ï101.8) and median disease-free survival (DFS) was 20.6 months (14.2ï26.9), all patients included. Univariate analysis showed that MCL International Prognostic Index and neutrophil count effected OS in all groups (pï½0.047 and pï½0.001). Multivariate analysis showed that the neutrophil count at diagnosis was independent prognostic risk factor (HR=0.209, 95% confidence interval 0.069-0.629, pï½0.005) for OS. The median OS was 77.8 months in absolute neutrophil count (ANC) less than 7.5ï´103/µL and 14.8 months in ANC more than 7.5ï´103/µL (pï½0.001).CONCLUSIONS:
Median OS is somewhat prolonged in the last years with new treatment approaches but MCL is still an incurable disease. The first choice of treatment in MCL patients was R-CHOP. Higher neutrophil count at the time of diagnosis has a detrimental effect on OS.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Prognóstico
/
Linfócitos B
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Linfoma de Célula do Manto
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article